Percutaneous Estrogen Replacement Therapy: Effects on circulating estrogens, gonadotropins and prolactin

References

• Baird D. T., Guevara A. Concentration of unconju-gated estrone and estradiol in peripheral plasma in non-pregnant women throughout the menstrual cycle, castrate and postmenopausal women and in men. J Clin Endocrinol Metab 1969; 29: 149
   PubMed Web of Science ®Google Scholar
• The Boston Collaborative Drug Surveillance Program. Surgically confirmed gallbladder disease, venous throm-boembolism, and breast tumors in relation to postmenopausal estrogen therapy. New Engl J Med 1974; 290: 15
   Google Scholar
• Carlström K., Sköldefors H. Determination of total oestrone in peripheral serum from nonpregnant humans. J Steroid Biochem 1977; 8: 1127
   PubMedGoogle Scholar
• The Coronary Drug Project: Findings leadings to discontinuation of the 2.5/day estrogen group. JAMA 1973; 226: 652
   PubMedGoogle Scholar
• Crane M. G., Harris J. J., Winsor W., III. Hypertension, oral contraceptive agents, and conjugated estrogens. Ann Intern Med 1971; 74: 13
   PubMed Web of Science ®Google Scholar
• Ehara Y., Siler T. N., Yen S. S. C. Effects of large doses of estrogen on prolactin and growth hormone release. Am J Obstet Gynecol 1976; 125: 455
   PubMed Web of Science ®Google Scholar
• Englund D. E., Johansson E. D. B. Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin). Br J Obstet Gynaecol 1978; 85: 957
   PubMedGoogle Scholar
• Geola F. L., Frumar A. M., Tataryn I. V., Lu K. H., Hersham J. M., Eggena P., Sambhi M. H., Judd H. L. Biological effects of various doses of conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab 1980; 51: 620
   PubMed Web of Science ®Google Scholar
• Hawkins R. A., Oakey R. E. Estimation of estrone sulphate, estradiol-17β and estrone in peripheral plasma. Concentrations during the menstrual cycle and in men. J Endocrinol 1974; 60: 3
   PubMed Web of Science ®Google Scholar
• La Groua Weill-Hallé M.-A. Estrogénotherapie per-cutanée de la ménopause. Rev Franc Gynéc 1977; 72: 283
   Google Scholar
• Helgason S., Carlström K., Damber M.-G., von Schoultz B. Gonadotropins and prolactin during estrogen replacement therapy. Acta Obstet Gynecol Scand 1981; 60: 515
   Web of Science ®Google Scholar
• Helgason S., Wilking N., Carlström K., Damber M.-G., von Schoultz B. A comparative study on the estrogenic effects of tamoxifen and estradiol-17β in postmenopausal women. J Clin Endocrinol Metab 1982; 54: 404
   PubMed Web of Science ®Google Scholar
• Helgason S. Estrogen replacement therapy after the menopause. Estrogenicity and metabolic effects. Acta Obstet Gynecol Scand Suppl 107 1982
   Google Scholar
• Judd H. L., Cleary R. E., Creasman W. T., Figge D. C., Kase N., Rosenwaks Z., Tagatz G. E. Estrogen replacement therapy. Am J Obstet Gynecol 1981; 58: 267
   Google Scholar
• Lindberg B. S., Lindberg P., Martinsson K., Johansson E. D. B. Radioimmunological methods for the estimation of oestrone, oestradiol-17β and oestriol in pregnancy plasma. Acta Obstet Gynecol Scand Suppl 1974; 32
   Google Scholar
• Lyrenäs S., Carlström K., Bäckström T., von Schoultz B. A comparison of serum oestrogen levels after percutaneous and oral administration of oestra-diol-17β. Br J Obstet Gynaecol 1981; 88: 181
   PubMedGoogle Scholar
• March C. M., Marrs R. P., Goebelsman U., Mishell D. R. Feedback effects of estradiol and progesterone upon gonadotropin and prolactin release. Obstet Gynecol 1981; 58: 10
   PubMedGoogle Scholar
• Nimrod A., Ryan K. J. Aromatization of androgens by human abdominal and breast fat tissue. J Clin Endo-crinol Metab 1975; 40: 367
   PubMed Web of Science ®Google Scholar
• Poller L., Thomson J. M., Coope J. Conjugated equine oestrogens and blood clotting: A follow-up report. Br Med J 1977; i: 935
   Google Scholar
• Ryan K. J., Engel L. L. The interconversion of es-trone and estradiol by human tissue slices. Endocrinology 1953; 52: 287
   PubMed Web of Science ®Google Scholar
• Whitehead M. I., Townsend P. T., Kitchin Y., Dyer G., Iqbal M. J., Mansfield M. D., Young O., Minardi J. Plasma steroid and protein hormone pro-files in postmenopausal women following topical administration of oestradiol-17β. Percutaneous Absorption of Steroids, P. Mauvais-Jarvis, C. F. H. Vickers, J. Wepierre. Academic Press, New York 1980; 231–247
   Google Scholar
• Widholm O., Vartiainen E. The absorption of conjugated oestrogen and sodium oestrone sulphate from the vagina. Ann Chir Gynaecol 1977; 63: 186
   Google Scholar
• Yen S. S. C., Martin P. L., Burnier A. M., Czekala N. M., Creaney M. O., Jr., Callantine M. R. Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17β-estradiol in postmenopausal women. J Clin Endocrinol Metab 1975; 10: 518
   Google Scholar